Mohamed A Ghoneim

6PUBLICATIONS
8CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsRegenerative medicine (incl. stem cells)Powder and particle technologyMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 28, 2024
Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration.

Mohamed A Ghoneim, Mahmoud M Gabr, Sawsan M El-Halawani

|Jul 26, 2022
Transplantation of insulin-producing cells derived from human mesenchymal stromal/stem cells into diabetic humanized mice.

Mohamed A Ghoneim, Mahmoud M Gabr, Ayman F Refaie

|Sep 04, 2020
From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges.

Mohamed A Ghoneim, Ayman F Refaie, Batoul L Elbassiouny

|Feb 14, 2020
PRDX6 Promotes the Differentiation of Human Mesenchymal Stem (Stromal) Cells to Insulin-Producing Cells.

Mahmoud M Gabr, Mahmoud M Zakaria, Ayman F Refaie

|Jun 07, 2017
From Human Mesenchymal Stem Cells to Insulin-Producing Cells: Comparison between Bone Marrow- and Adipose Tissue-Derived Cells.

Mahmoud M Gabr, Mahmoud M Zakaria, Ayman F Refaie

Pageof 1